Backtest Vs Live Performance

Published 2026-01-02. Last updated 2026-04-17. Editorial review: Know Your PMS editorial standards. By Abhimanyu Kucheria for Know Your PMS.

Topic cluster: Evaluation & Due Diligence

Start here if you are building a shortlist or reading factsheets for the first time. These guides cover comparison frameworks, disclosure literacy, and the traps that make good marketing look like good performance.

Pillar guide: How To Compare Schemes

More in this cluster:

• How To Compare Schemes
• How To Read Factsheet
• Common Pms Red Flags
• Benchmark Selection
• Peer Group Comparisons

What it means (plain English)

A backtest applies today's strategy rules to historical prices—often with the benefit of hindsight on which stocks 'would have' been held. Live performance is what actual clients experienced after fees, slippage, capacity limits, and real-world execution.

In Indian PMS marketing, backtests frequently appear for newer strategies or refreshed mandates. SEBI guidelines require clear labeling, but the gap between simulated and realized returns can still be wide. Common reasons: survivorship in the stock universe, optimistic fill assumptions, ignoring market impact in illiquid small caps, and not modeling the cash drag of gradual deployment.

Live track records also reflect composite construction—how the manager blends model and client accounts, treats large inflows, and handles corporate actions. A backtest might assume instant full investment on day one; your account may have scaled in over weeks.

For due diligence, treat backtests as hypothesis tests, not proof. Ask for the live composite since inception (or since strategy launch), compare turnover and holdings overlap with the simulation, and note whether the manager has traded this exact process through at least one correction.

Worked example (Indian PMS scenario)

A small-cap PMS launched in January 2022 markets a 10-year backtest showing 22% CAGR versus Nifty Smallcap 250 at 15%. The live composite since launch: 14% net of fees through March 2025. The gap is not fraud—it reflects ₹80 crore of AUM trying to enter names with ₹50–200 crore market caps, plus 18-month phased deployment that the backtest assumed was instant.

Run the overlap test. In FY23 the backtest assumed 120% annual turnover; live composite turnover was 85% with higher cash (12% average) during inflows. Slippage on a ₹25 lakh position in a thinly traded SME can cost 40–80 bps per round trip; at 85% turnover on ₹1 crore, that alone can shave 0.7–1.2% from annual returns.

Weight your decision: if live covers fewer than 24 months, treat backtest as illustrative only. A ₹50 lakh allocation should demand at least one live drawdown (e.g., Oct 2023 correction) where you can verify the composite fell less than—or proportionally to—the simulated path.

Why it matters for PMS scheme selection

Backtests sell the dream; live composites reveal execution reality—critical when many Indian PMS launches lean on simulated histories.

See the complete PMS evaluation framework

• Prevents overpaying for performance that never existed in client accounts
• Surfaces hidden assumptions in liquidity, fees, and position sizing
• Shows whether the manager has actually navigated a live drawdown
• Helps you weight live years more heavily than simulated ones
• Protects against strategies optimized to fit past data perfectly

How to interpret it (practical checklist)

1. Identify which portions of the track record are backtested vs live
2. Request live composite returns net of fees since strategy inception
3. Compare simulated turnover and holdings to current live portfolio
4. Check whether backtest assumes instant deployment vs phased investing
5. Review disclosure footnotes for survivorship or point-in-time bias
6. Ask how capacity and AUM growth changed execution post-launch
7. Stress-test by mentally removing the best backtest year

Explore related metrics · Compare PMS schemes · Cagr

Common pitfalls (how this gets misused)

Read our methodology for assumptions and limitations.

• Ranking a scheme primarily on a long backtest with few live years
• Ignoring slippage assumptions in illiquid Indian small caps
• Assuming backtested alpha will repeat at higher AUM
• Overlooking that rules may have changed after seeing the simulation
• Comparing backtest gross returns to live net returns
• Treating manager 'paper portfolios' as equivalent to audited composites

Related metrics to review together

Use this guide alongside these metrics to avoid one-number decision-making:

Browse all metrics

• Cagr
• Max Drawdown
• Sharpe
• Volatility

Related guides

• Fees Fixed Vs Performance
• Bull Vs Bear Market Performance
• PMS Sharpe Vs Sortino
• Performance Persistence Myth
• Max Drawdown Explained

See also

• Survivorship bias
• Performance persistence myth
• Common PMS red flags
• How to read a factsheet

FAQs

Is it legal for Indian PMS to market backtested returns?

SEBI permits performance advertising with strict conditions: clear identification of simulated results, methodology disclosure, and no suggestion that backtests are as reliable as live track records. Ethical managers separate the two visually. Your job is to discount simulated periods appropriately in any comparison.

How much worse should I expect live vs backtest?

No fixed rule. Liquid large-cap strategies may track closely; high-turnover small-cap or momentum styles often see 1–3% annual degradation from slippage and capacity. The spread widens with AUM. Compare live inception returns to the overlapping backtest window for the same dates.

What should I trust if live history is only 18 months?

Weight live heavily for process and execution, use backtest only for economic intuition. Require overlap analysis: did live holdings resemble the simulation? Did drawdown behavior match? Short live records plus long backtests deserve skepticism, not enthusiasm.

Next: How to compare PMS schemes · Compare schemes · All guides